S. Tannous

Incidence and risk factors of hospitalisations for respiratory syncytial virus among children aged less than 2 years

S. Freimann, U. Obolski, K. Muhsen, 2022, Epidemiology and Infection.

BNT 13b2 Pfizer vaccine protects against SARS-CoV-2 respiratory mucosal colonization even after prolonged exposure to positive family members

S. Zarka, Shimon Edelstein, Hila Ben-Amram, 2021, Journal of Hospital Infection.

Unnecessary antibiotic treatment of children hospitalized with RSV-bronchiolitis: risk factors and prescription patterns: Risk factors for antibiotic misuse in children with RSV.

U. Obolski, K. Muhsen, W. Na’amnih, 2021, Journal of global antimicrobial resistance.

Unnecessary antibiotic treatment of children hospitalized with RSV-bronchiolitis: risk factors and prescription patterns

U. Obolski, K. Muhsen, W. Na’amnih, 2021, medRxiv.